Rothschild, S. I. (2014). Ceritinib—a second-generation ALK inhibitor overcoming resistance in ALK-rearranged non-small cell lung cancer. Transl Lung Cancer Res.
Citação norma ChicagoRothschild, Sacha I. "Ceritinib—a Second-generation ALK Inhibitor Overcoming Resistance in ALK-rearranged Non-small Cell Lung Cancer." Transl Lung Cancer Res 2014.
MLA citiranjeRothschild, Sacha I. "Ceritinib—a Second-generation ALK Inhibitor Overcoming Resistance in ALK-rearranged Non-small Cell Lung Cancer." Transl Lung Cancer Res 2014.
Opozorilo: Ti citati niso vedno 100% točni.